Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors

Class I histone deacetylases, HDAC1, HDAC2, and HDAC3, represent potential targets for cancer treatment. However, the development of isoform-selective drugs for these enzymes remains challenging due to their high sequence and structural similarity. In the current study, we applied a computational ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bülbül, Emre F., Melesina, Jelena, Ibrahim, Hany S., Abdelsalam, Mohamed, Vecchio, Anita, Robaa, Dina, Zessin, Matthes, Schutkowski, Mike, Sippl, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032825/
https://www.ncbi.nlm.nih.gov/pubmed/35458724
http://dx.doi.org/10.3390/molecules27082526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032825/
https://www.ncbi.nlm.nih.gov/pubmed/35458724
http://dx.doi.org/10.3390/molecules27082526

Ejemplares similares